Seroconversion after three doses of intramuscular rabies vaccine as a post-exposure treatment

2020 ◽  
Vol 278 ◽  
pp. 197883
Author(s):  
Alireza Gholami ◽  
Mohammad-Reza Shirzadi ◽  
Mohsen Asouri ◽  
Firouzeh Farahtaj ◽  
Ehsan Mostafavi ◽  
...  
2019 ◽  
Vol 30 (12) ◽  
pp. 589-594
Author(s):  
Hilary Simons ◽  
Rachael Fletcher ◽  
Katherine Russell

Practice nurses have an important role to play in raising the profile of rabies as a travel-related hazard. Hilary Simons, Rachael Fletcher and Katherine Russell give an update for nurses working in this area of practice Many thousands of human deaths are attributed to rabies infection globally each year; once the symptoms of rabies occur, death is almost always inevitable. Rabies is a zoonosis—a disease of animals that can be transmitted to humans—and can occur in all warm-blooded animals. Rabies remains a neglected disease that impacts most on impoverished and disadvantaged populations living in rabies endemic regions, who may have limited or no access to good healthcare facilities and safe rabies vaccine products. Practice nurses are well placed to raise travellers' awareness of the risk of rabies at a destination, and provide guidance on pre-travel vaccination and post-exposure treatment.


2011 ◽  
Vol 12 (2) ◽  
pp. 153-159
Author(s):  
Mohammad Robed Amin

Background: Rabies has been the subject of fear ever since the disease was recognized. Worldwide the number of deaths annually, due to rabies, is estimated to be between 35,000 to 50,000 approximately Rabies continues to be a major public health problem in Bangladesh killing an estimated 2000 people annually and 100,000 people receive post-exposure treatment in the country. In this regard the post-exposure treatment of animal bite cases is of prime importance. Materials and Methods: Communicable disease control(CDC) of, Directorate General of Health Services (DGHS) took the noble initiative to establish the national rabies elimination programme 2010 with an comprehensive approach of care for human and control of rabid animal.  An expert group meeting for strategic plan and finalizing the guidelines for prevention and control of rabies cases was held in 2010, under CDC of DGHS to bring out uniformity in post-exposure treatment practices. . The participants in the meeting included practitioners managing anti-rabies clinics, laboratory medicine practitioners, policy makers, public health experts from both public and private sector. The guideline, which emerged out of consensus of expert groups, is summarized in this paper. Results: Until recently the Nervous Tissue Vaccine (NTV) was the mainstay for post-exposure prophylaxis in Bangladesh. As per WHO recommendations, the production and use of this reactogenic vaccine should be gradually phased out from our country. Modern, safe and effective anti-rabies Cell Culture Vaccines (CCVs) will be used for post-exposure prophylaxis in public sectors. The limitation is the high cost of this vaccine and also the cost and unavailability of Anti Rabies Immunoglobulin. WHO recommended the use of intra-dermal (ID) route of application of CCVs. Considering the recommendations of experts, results of clinical trials and international experience, experts of Bangladesh recommends ID regimen phase wise. In first phase, only Dhaka Infectious Disease Hospital will serve as Anti-rabies centre for ID regimen. After its successful implementation, ID regimen will spread out to Division and then to District level hospitals. National experts suggested and recommended the use of cost-effective vaccination schedules such as abbreviated multisite IM Zagreb protocol (4 dose, 3 visits) and updated Thai Red Cross (TRC) intradermal regimen(2-2-2-0-2) to phase out NTV and to make available modern rabies vaccine in public sector. Conclusion: This guideline will be extremely useful for the country to make rational use of modern rabies vaccine and phase out NTV by 2011. The guideline will be of immense use for better management of animal bite cases and availability and affordability of modern rabies vaccine will be of great help for physician to manage appropriately for preventing  the deadly disease rabies. DOI: http://dx.doi.org/10.3329/jom.v12i2.7691 JOM 2011; 12(2): 153-159


2007 ◽  
Vol 3 (1) ◽  
pp. e2 ◽  
Author(s):  
Heinz Feldmann ◽  
Steven M. Jones ◽  
Kathleen M. Daddario-DiCaprio ◽  
Joan B. Geisbert ◽  
Ute Ströher ◽  
...  

Vaccine ◽  
2011 ◽  
Vol 29 (21) ◽  
pp. 3742-3745 ◽  
Author(s):  
Ahmad Fayaz ◽  
Susan Simani ◽  
Alireza Janani ◽  
Firouzeh Farahtaj ◽  
Peyvand Biglari ◽  
...  

Vaccine ◽  
2016 ◽  
Vol 34 (40) ◽  
pp. 4820-4826 ◽  
Author(s):  
Anuradha Bose ◽  
Renuka Munshi ◽  
Radha Madhab Tripathy ◽  
Shampur N. Madhusudana ◽  
B.R. Harish ◽  
...  

2019 ◽  
Vol 24 (1) ◽  
pp. 315-322 ◽  
Author(s):  
Bruno Fonseca Martins da Costa Andrade ◽  
Taísa Santos de Melo Andrade ◽  
Luzia Helena Queiroz

Abstract This study evaluated the prophylactic measures adopted after attacks by dogs and cats in the main city of Northwester São Paulo State, based on the technical manual for post-exposure treatment, considering the not controlled (1990-1996) and controlled (1997-2010) rabies status. A retrospective analysis was done using the data from the SINAN records (W64-CID10) between 1990 and 2010. In most cases, the accidents were mild (76.9%), and biting animals were healthy (75.4%); therefore, no treatment was needed in 53.3% of the cases. In 64.6% of cases, the prescribed PEP treatment was inappropriate. The most indicated PEP treatments consisted of vaccine and RIG (43.4%), and either three doses of mouse brain vaccine or two doses of cell culture vaccine (76.5%), during the not controlled and controlled rabies periods, respectively. The treatment was more appropriate and followed the technical recommendations during controlled rabies periods compared to not controlled (p < 0.0001) periods. However, excessive application of RIG and rabies vaccine was observed in both periods.


Author(s):  
Rosuita Fratari Bonito ◽  
Neide Mattar de Oliveira ◽  
Sérgio de Andrade Nishioka

The Fuenzalida-Palacios rabies vaccine has been used in South America for rabies post-exposure prophylaxis. To determine the frequency of adverse reactions associated with this vaccine compared to a control group a quasi-experimental study was carried out in Uberlândia, Brazil, from May 1997 to April 1998. Victims of bites or other injuries by dogs or other mammals and who received or not post-exposure prophylaxis with Fuenzalida-Palacios rabies vaccine were compared as to the occurrence of a list of signs and symptoms. Out of 2,440 victims of bites and other injuries from dogs and other mammals 2,114 participated in the study; 1,004 of them provided follow-up information within 10 to 15 days. Headache and pain at the injection sites were the most commonly found symptoms (125/1,000). No neuroparalytic event was detected. Patients who were given Fuenzalida-Palacios rabies vaccine and those who were not had similar incidences of symptoms (risk ratios close to 1). Regarding the occurrence of adverse reactions, Fuenzalida-Palacios rabies vaccine is a valid alternative for rabies post-exposure prophylaxis.


Sign in / Sign up

Export Citation Format

Share Document